CNBX PHARMACEUTICALS INC. Sale of Stock, Consideration Received on Transaction
CNBX PHARMACEUTICALS INC. (CNBX) reported Sale of Stock, Consideration Received on Transaction of $114.67 thousand for the 0-month period ending 2024-02-15, per its 10-K filed 2024-11-29.
Financial Statements › Notes
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2024-11-29
- 2024-02-15: Sale of Stock, Consideration Received on Transaction 0 month $114.67K.
- 2022-12-09: Sale of Stock, Consideration Received on Transaction 0 month $24.20K.
| Period end | Sale of Stock, Consideration Received on Transaction 0 month |
|---|---|
| 2024-02-15 | $114.67K 10-K · filed 2024-11-29 |
| 2022-12-09 | $24.20K 10-K · filed 2024-11-29 |